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osting by EAbstract The purpose of this study was investigating experimentally the possible antitumor effect
of ethanol extract of root of Lawsonia inermis against Dalton’s lymphoma ascites (DLA) bearing
mice.
Mice were administered with L. inermis at a dosage of 180 mg/kg of body weight for 15 days after
24 h of DLA inoculation. The ethanolic root extract of L. inermis reverted the increased number of
the WBC count, platelets and lymphocytes and decreased the number of the RBC count, hemoglo-
bin content and monocytes. The effect of root extract of L. inermis also increased the pathophys-
iological marker enzyme, lipid proﬁle and decreased the enzymic and non enzymic antioxidants.
A histopathological result shows the loss of liver hepatocytes and kidney architecture in DLA bear-
ing mice. However, mice treatment with L. inermis extract improves the liver and kidney function
and rearranges more or less normal architecture. The present work indicates that the ethanol extract
of L. inermis exhibited signiﬁcant antitumor activity.
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lsevier1. Introduction
There is a growing interest in the pharmacological evaluation
of various plants used in Indian traditional medicine. The
plant Lawsonia inermis in a ﬂowering plant belongs to the fam-
ily Lytheraceae, which is distributed in dry tropical and sub-
tropical zones including North Africa, India, Srilanka and
the Middle East (Chung et al., 2002). L. inermis produces a
burgundy dye molecule, lawsone (2-hydroxy-1,4 napthaqui-
none) is an active napthaquinone derivative isolated from hen-
na which gives dyeing properties. The plant is used as a
medicine for jaundice, leprosy, smallpox, and skin complaints
(Kazandjieva et al., 2007). It has a long history of use in the
treatment of cancer.and has played an important role as a
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over 60% of currently used anticancer agents are derived in
one way or another from natural sources including plants
and marine organisms (Kadam et al., 1989).
The hepatoprotective activity of the 50% ethanol extract of
the bark of L. inermis was investigated against the carbon tetra
chloride induced oxidative stress. The plant extract signiﬁ-
cantly lowered serum transaminases (AST and ALT) and
LDH levels and prevented CCl4 induced oxidative stress by
signiﬁcantly maintaining the levels of reduced glutathione
(GSH) and its metabolizing enzyme and simultaneously inhib-
iting the production of the free radicals (Ahmed et al., 2000).
The present study was carried out to evaluate the anticancer
activity of ethanolic root extract of L. inermis against DLA cell
line bearing mice.2. Materials and methods
2.1. Plant material and extraction
The root of L. inermis (Lytheraceae) was collected from differ-
ent places of Thanjavur district. The root was washed and cut
into small pieces and then air dried under shade. Ten gram of
dried powdered roots was extracted with 70% ethanol solvent
and concentrated under reduced pressure and then preserved
in an airtight bottle until further use (Chopra et al., 1981).
The plant was taxonomically identiﬁed and authenticated by
Rev. Dr. S. John Britto SJ, Director, The Rapinat Herbarium
and Centre for Molecular Systematics, St. Joseph College
(Autonomous), Tiruchirapalli, Tamilnadu, India. The voucher
specimen was deposited at the Rapinat Herbarium and the
voucher number is RHCDBP2010.2.2. Animals
Swiss albino mice were obtained from Kerala Agriculture Uni-
versity. The animals weighing 25–28 g were housed in conven-
tional cages with free access to water and fed ad libitum and
kept at constant room temperature (22–25 C) with 12 h of
light and darkness. The animals were acclimatized to the lab-
oratory for 2 week’s before the inception of experiments. All
the animal experiments were duly approved by the Institu-
tional Animal Ethics Committee (743/03/abc/ CPCSEA dt
3.3.03) Guidelines.2.3. Cell line
DLA cell lines were supplied by Amala Cancer Research
Centre, Thrissur, Kerala, India. The cells were maintained by
intraperitoneal inoculation of 1 · 106 viable cells in mice.2.4. Tumor transplantation
DLA was maintained by serial transplantation from tumor
bearing swiss albino mice at the log phase (day 78 of tumor
bearing) of the tumor cells. The tumor cell number was ad-
justed to 1 · 106 tumor cells/mL sample showing more than
90% viability which was used for transplantation. Each animal
received 0.2 mL of tumor cell suspension containing
1 · 106 cells/mL intraperitonealy (Sivakumar et al., 2008).2.5. Treatment schedule
Swiss albino mice were divided into three groups. Group I
served as control group. Group II served as a tumor control
(DLA cells 1 · 106 cells). Group III were treated with the eth-
anol extract of L. inermis at 180 mg/kg body weight. Group IV
was administered intraperitonealy with well positive anticancer
compound. Group IV was administered intraperitonealy with
known anticancer compound Vincristine (1 mg/kg) and all
these treatments were given 24 h after the tumor inoculation
once daily for 15 days. At the end of the experimental period,
the animals were sacriﬁced by cervical dislocation. A portion
of the liver was ﬁxed in formalin for pathological examination.
2.6. Tumor growth response
Antitumor effect of L. inermis was determined by monitoring
the activity of mice with respective body weight, ascetic tumor
volume, packed cell volume, viable and non viable cell count,
mean survival time and increases in the life span (%ILS) were
also determined. Transplantable murain tumor was carefully
collected with the help of a sterile 3 mL syringe and the tumor
volume was measured and the packed cell volume was deter-
mined by centrifuge at 1000 rpm for 10 min, viable and non
viable cell counts were determined by the trypan blue dye
exclusion test. The effect of L. inermis on tumor growth was
monitored by daily recording the mortality rate of mice and
%ILS was calculated using the following formula
ILS ð%Þ
¼Mean survival of treated groupmean survival of control
Mean survival of control group
 100
2.7. Immunological analysis
Blood was taken from mice and was drawn into RBC or WBC
pipettes, diluted and counted in a Neubarer counting chamber.
Sahlis Haemoglobinometer is used for hemoglobin concentra-
tion. Differential count such as white blood cells (WBC), plate-
let, lymphocyte, Mean Corpuscular Volume (MCV), Mean
Corpuscular Hemoglobin (MCH) and Mean Corpuscular
Hemoglobin Concentration (MCHC) were done on freshly
drawn blood ﬁlm using leishmans stain.
2.8. Biochemical parameter
Aspartate transaminase (AST), alanine transaminase, lactate
dehydrogenase, alkaline phosphatase and cholesterol, triglyc-
eride (ALP), low density lipoprotein (LDL), high density lipo-
protein (HDL), albumin and globulin were estimated by using
commercially available kits according to the manufacturer’s
instruction (AGGAPPE Diagnostic, Kerala and ENSURE
BIOTECH, Hyderabad, India).
2.9. Histopathological analysis
A portion of the liver and kidney was cut into 2–3 pieces of
approximately 6 mm3 size and ﬁxed in 10% formaldehyde
solution. After embedding in parafﬁn wax, thin sections of
Table 1 Effect of L. inermis extract on body weight, tumor growth viable and non viable in experimental mice.
Experimental groups Control DLA control
2 · 106 cells/mouse/ml
DLA+L. inermis
extract180 mg/kg
of body weight
DLA+ Vincristine
1.0 mg mg/kg
of body weight
Body weight (g) 25.06 ± 0.3 29.4 ± 0.4a 26.09 ± 0.5b 24.12 ± 0.3b
Tumor volume (mL) – 4.26 ± 0.02a 3.31 ± 0.01b 1.24 ± 0.03b
Packed cell volume (mL) – 1.95 ± 0.07a 0.86 ± 0.03b 0.52 ± 0.04b
Viable tumor count · 107 cells mL1 – 21.2 ± 0.06a 12.52 ± 0.07b 8.35 ± 0.05b
Non viable tumor count · 107 cells mL1 – 0.21 ± 0.08a 1.24 ± 0.02b 2.16 ± 0.01b
Results were expressed as mean ± SD (n= 6).
a P< 0.05 compare with normal groups mice.
b P< 0.05 compare with DLA induced groups of mice.
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toxylin–eosin. The thin sections of liver were made into perma-
nent slides and examined (Kleiner et al., 2005) under high
resolution microscope with photographic facility and photomi-
crographs were taken.
2.10. Statistical Analysis
Data were evaluated with SPSS/10 software hypothesis testing
methods included one way analysis of variance (ANOVA) fol-
lowed by least signiﬁcant difference (LSD) test P values of less
than 0.05 that were considered to show statistical signiﬁcance.
All these results were expressed as mean ± SD for six animals
in each group.
3. Results
The Tables 1 and 2 showed that the body weight, tumor vol-
ume, packed cell volume, viable and non viable cells in the
experimental group of mice. The body weight, tumor volume,
packed cell volume and viable cells were abnormally increasedTable 2 Effect of L. inermis extract on mean of survival and
Increases in life span in experimental mice.
Experimental
groups
Mean of
survival days
%Increases in life
span (%ILS)
Control – –
DLA control 32 ± 1.2a –
DLA+L. inermis 43 ± 1.6b 34.37 ± 2.3b
DLA+ Vincristine 51 ± 1.4b 59.37 ± 2.5b
Results were expressed as mean ± SD (n= 6).
a P< 0.05 compare with normal groups mice.
b P< 0.05 compare with DLA induced group of mice.
Table 3 Effect of L. inermis on hematological parameter in albino
Experimental groups Hemoglobin (g/dl) RBC (m/c.mm)
Control 14.0 ± 0.01 4.91 ± 0.04
DLA control 7.09 ± 0.03a 2.56 ± 0.03a
DLA+ L. inermis 12.6 ± 0.02b 3.34 ± 0.06b
DLA+ Vincristine 13.4 ± 0.06b 3.82 ± 0.04b
Results were expressed as mean ± SD (n= 6).
a P< 0.05 compare with normal groups mice.
b P< 0.05 compare with DLA induced groups of mice.in the DLA bearing mice. However, it was brought back into
normal level by treatment with ethanolic extract of L. inermis
and Vincristine at a dosage of 180 and 1 mg of per kg of body
weight, respectively. Mean survival time and life span of mice
were increased when treated with the ethanolic extract of L.
inermis.
The experimental results showed that the immunological
parameters like WBC, platelet and lymphocytes were increased
in the DLA bearing mice and decrease the hemoglobin, RBC,
PCV, monocytes, differential count compared to those of con-
trol mice (Tables 3 and 4). However, the root extract of etha-
nolic extract of L. inermis treatment reversed these changes
toward normal values.
Table 5 illustrates the pathophysiological marker enzymes
like ALT, AST, ALP and LDH in control and experimental
animal. The activities of ALT, AST, ALP and LDH in DLA
induced mice were elevated when compared to control group
of mice. However, mice treatment with ethanolic extract of
L. inermis was normalized altered level of ALT, AST, ALP
and LDH.
Table 6 shows the lipid proﬁle, such as cholesterol, tri-
glyceride, LDL, HDL and VLDL in control and experimen-
tal animals. The lipid proﬁle of DLA control mice showed
signiﬁcant increases in serum cholesterol, triglyceride, LDL
and VLDL but decreased serum HDL level when compared
with control mice. Nevertheless, mice treatment with root
extract of L. inermis and Vincristine was brought back to
normal level.
Table 7 represents the effect of L. inermis on serum albumin
and globulin level in control and experimental animals. The
amount of serum albumin and globulin was reduced in the
DLA bearing mice when compared with control group of mice.
Conversely, the amount of serum albumin and globulin was in-
creased by the L. inermis treatment. It indicates that this plant
extract possessed the antitumor activity.mice.
PCV% Monocytes (%) Dentritic cells (%)
41 ± 0.02 3 ± 0.04 38 ± 1.2
23 ± 0.01a 1 ± 0.06a 20 ± 0.8a
39 ± 0.06b 2 ± 0.03b 25 ± 0.04b
42 ± 0.08b 2 ± 0.01b 27 ± 0.6b
Table 4 Effect of L. inermis on differential count in albino mice.
Groups WBC (c.mm) Platelet (Lakhs/c.mm) Lymphocyte (%) MCV (L/cell) MCH (gm/cell) MCHC (gm/L)
Control 2000 ± 12.3 7.91 ± 0.02 59 ± 1.0 83 ± 1.4 28.1 ± 0.05 34.14 ± 0.3
DLA control 18,700 ± 52.3a 15.28 ± 0.05a 80 ± 6.2a 91 ± 0.9a 30.4 ± 0.5a 33.76 ± 0.7a
DLA+ L. inermis 4512 ± 14.6b 10.32 ± 0.08b 74 ± 1.8b 116 ± 0.8b 37.2 ± 0.2b 32.30 ± 0.4b
DLA+ Vincristine 3965 ± 26.1b 10.12 ± 0.05b 65 ± 2.8b 96 ± 0.5b 38.26 ± 0.6b 32.82 ± 1.9b
Results were expressed as mean ± SD (n = 6).
a P< 0.05 compare with normal groups mice.
b P< 0.05 compare with DLA induced groups of mice.
Table 5 Estimation of serum marker enzymes in control and experimental albino mice.
Groups AST U/L ALT U/L ALP U/L LDH U/L
Control 11.63 ± 0.03 29.0 ± 0.07 284 ± 0.09 320 ± 0.07
DLA control 23.2 ± 0.09a 34.6 ± 0.06a 348 ± 0.21a 427 ± 0.08a
DLA+ L. inermis 14.82 ± 0.04b 23.26 ± 0.05a 321 ± 0.08a 320 ± 0.01a
DLA+ Vincristine 11.21 ± 0.05a 21.03 ± 0.08a 306 ± 0.04a 310 ± 0.05a
Results were expressed as mean ± SD (n = 6).
a P< 0.05 compare with normal groups mice.
b P< 0.05 compare with DLA induced groups of mice.
Table 6 Quantiﬁcation of lipid proﬁles in control and experimental albino mice.
Experimental groups TG mg/dl Cholesterol (mg/dL) LDL (mg/dL) HDL (mg/dL)
Control 80.04 ± 0.7 150.04 ± 0.4 7.03 ± 0.01 35.04 ± 0.9
DLA control 160.0 ± 0.4a 253.05 ± 0.3a 14.3 ± 0.01a 21.05 ± 0.5a
DLA+ L. inermis 126.0.±0.2b 165.04 ± 0.1b 9.2 ± 0.01b 27.05 ± 0.3b
DLA+ Vincristine 96.26 ± 0.8b 162.02 ± 0.5b 8.2 ± 0.06b 32.6 ± 0.8b
Results were expressed as mean ± SD (n= 6).
a P< 0.05 compare with normal groups mice.
b P< 0.05 compare with DLA induced groups of mice.
Table 7 Quantiﬁcation of serum albumin and globulin in
control and experimental albino mice.
Experimental groups Albumin (gm/dL) Globulin (gm/dL)
Control 1.94 ± 0.07 3.17 ± 0.65
DLA control 1.06 ± 0.07a 4.35 ± 0.26a
DLA+L. inermis extract 1.73 ± 0.06b 3.26 ± 0.61b
DLA+ Vincristine 1.76 ± 0.02b 3.12 ± 0.42b
Results were expressed as mean ± SD (n= 6).
a P< 0.05 compare with normal groups mice.
b P< 0.05 compare with DLA induced groups of mice.
Table 8 Determination of antioxidant activity in control and exper
Experimental groups Vitamin C (mg/dL) Vitamin E (mg/dL)
Control 5.54 ± 0.08 467.3 ± 2.34
DLA control 3.33 ± 0.05a 413.0 ± 2.62a
DLA+L. inermis extract 4.43 ± 0.08b 434.07 ± 2.8b
DLA+ Vincristine 4.62 ± 0.06b 452.02 ± 1.32b
Results were expressed as mean ± SD (n= 6).
* lmol 1-chloro-2,4-dinitrobenzene conjugate formed min1 mg1 protei
a P< 0.05 compare with normal groups mice.
b P< 0.05 compare with DLA induced groups of mice.
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of L. inermis. It shows the decreased level of antioxidants like
vitamin C and E, GST and GPx but an increase in serum cat-
alase. Moreover, mice administered with ethanolic extract of
L. inermis were reverted to the normal level when compared
with DLA bearing mice (Table 8).
Fig. 1 shows the histopathological observation of liver sec-
tion of control and experimental animals. Control animals
showed normal liver architecture with intact central vein, well
preserved hepatocytes, prominent nucleus and nucleolus
whereas DLA induced mice showed loss of inﬁltration of cells,imental albino mice.
GST * GPx (U/Mg) Catalase (U/Mg) MDA (nm/mg)
59.4 ± 0.007 145.5 ± 0.09 12.5 ± 0.7 0.6 ± 0.04
40.65 ± 0.01a 97.1 ± 0.04a 12.7 ± 0.9a 1.7 ± 0.06a
53.2 ± 0.07b 129.5 ± 0.01 14.21 ± 0.6 1.0 ± 0.02
62.31 ± 2.8b 132.3 ± 0.01b 14.9 ± 0.2b 0.8 ± 0.01
n.
Figure 1 (A) Histology of control mice liver shows the normal
hepatocytes, nucleus, vacuoles, central vein sinusoids. (B) DLA
control mice shows deformation of central vein, loss of architec-
ture. Well developed hepatocytes with prominent nucleus and
maintained sinusoidal space after L. inermis (C) and Vincristine
(D) administered.
Figure 2 (A) control mice kidney architecture, (B) DLA control
kidney architecture, it shows some alteration in glomeruli region.
Regeneration of glomeruli region after L. inermis (C) and
Vincristine (D) administered.
Effect of Lawsonia inermis on tumor expression induced 357disturbed hepatocytes, nucleus and vacuoles. However, mice
treated with L. inermis extract showed almost normal hepato-
cellular architecture.
Kidney sections showed normal glomeruli and architecture
intactness without any apparent damages in control, but incase of DLA induced mice, it showed glomerular damage.
However, the histopathological of kidney lesions induced by
DLA cells were signiﬁcantly prevented by the L. inermis and
Vincristine treatment. These histology results were greatly in-
line with the result of serum marker enzymes (Fig. 2).
4. Discussion
Although, cancer takes part among the top of death list in re-
cent years, its treatment is still very complicated and has great
preconditions. In this complexity, numerous natural agents
358 R. Priya et al.which were used traditionally have a signiﬁcant role in ﬁghting
cancer such as protective, preventive and curative consolidated
immune system. The substances extracted from plants and sug-
gested as active were tested in the experimental cancer model
studies (Jagethia and Baliga, 2003). Similarly, the L. inermis
extracts can prevent the tumor cells multiplication in the
DLA induced mice and increased the mean survival time and
life span of mice. So, these indicate that the L. inermis extracts
possess the antitumor properties.
Haiping et al. (2008) reported that the treatment with LPS-
CP-2 doses (204,060 mg/kg) all signiﬁcantly increased the
hemoglobin content, RBC, eosinophils and signiﬁcantly de-
creased the total WBC and neutrophils counts nearly to nor-
mal levels. The tumor bearing mice showed reduced number
of RBC and low level of hemoglobin but total WBC count
was increased in DLA bearing mice. Anemia is found fre-
quently in cancer patients. The hemoglobin content, RBC,
platelets and differential count of WBC were reversed by the
LPS-CP-2 treatment. Similarly our results showed that the to-
tal RBC count, hemoglobin, monocytes, packed cell volume
and dentritic cells were decreased and the total WBC count,
platelets, lymphocyte were increased in DLA control group
as compared to control group. This has almost come to the
normal level when it was treated with the root extract of L.
inermis. This is indicating that our plant extract possessed
the antitumor activity.
AST and ALT are found in serum and in various bodily tis-
sues but are most commonly associated with the liver. Aspar-
tate transaminase also called as serum glutamic oxaloacetic
transaminase and glutamic pyruvate transaminase called as
alanine transaminase are associated with liver parenchymal
cells. It is raised in acute liver damage (Gaze, 2007). ALP levels
in plasma will rise with large bile duct obstruction, intrahepatic
cholestasis or inﬁltrative diseases of the liver (Harada et al.,
1986). Similarly, the present study indicated that DLA bearing
mice showed higher level of AST, ALT, LDH and ALP when
compared with the control group of mice. However, it was re-
versed to nearly the normal level by the ethanolic extract of L.
inermis treatments. Similarly lipid proﬁle and protein proﬁle
were also normalized by treatment with this plant root extract.
Ascorbic acid is the most powerful antioxidant under phys-
iological conditions. It exists in the reduced form which is di-
rectly scavenged by the superoxide radicals, hydroxyl
radicals and single oxygen. Hydrogen peroxide was converted
into water by ascorbic acid via ascorbate peroxidase reaction
(Noctor and Foyer, 1998). GSH conjugation plays a critical
role in eliminating the toxic metabolites which are the major
cause of liver pathology (Lee et al., 2008). SOD is an important
defense enzyme which catalyzes the dismutation of superoxide
radicals to hydrogen peroxide thereby reducing the likelihood
of superoxide anion interacting with NO to form reactive per-
oxynitrite (Maritim et al., 2003). Hydrogen peroxide is succes-
sively metabolized into water and non reactive oxygen species
by the activities of catalase and GPx (Mate´s and Sanchez-
Jime´nez, 1999). Marklund et al. (1984) reported that DLA
bearing mice showed increased level of catalase activity in tu-
mor cell line and it was appreciably elevated by administration
of methanolic extract of Triumfetta rhomboidea suggesting that
it can restore the levels of catalase enzymes. However, mice
administered with L. inermis root extract signiﬁcantly en-
hanced the activities of catalase, glutathione peroxidase andglutathione S transferase and also increased the level of vita-
min C and E and reduced glutathione, which may be responsi-
ble for their antioxidant properties.
Histopathological assessment of different liver segments of
the control and experimental animals by light microscope has
been examined. Liver section of cell line (DLA) induced mice
showed structural alteration in nucleus. The major alteration
was damaged central vein, loss of hepatocytes, vacuolation.
This damage is partially reversed by the L. inermis root extract
treatment. The kidney histopathology micrograph of DLA in-
duced mice showed marked tubular and glomerular damage.
This damage is regenerated by the treatment with ethanolic
root extract of L. inermis, histopathological observations after
DLA administration showed severe damage in hepatocytes,
which basically supported the alterations observed in biochem-
ical assays.5. Conclusion
The present study demonstrated that the ethanolic extract of
L. inermis increased the life span of DLA tumor bearing mice
and it enhanced the antioxidant status and reduced the lipid
proﬁle. The architecture changes of cells in liver and kidney
were analyzed by histopathological analysis. It is proved that
the plant can be exploited as a source of novel drug develop-
ment for cancer treatment. More detailed investigations are
in progress to elucidate the antitumor activities of exact com-
pounds, which are present in this plant root.References
Ahmed, S., Rahman, A., Alam, A., Saleem, M., 2000. Evaluation of
the efﬁcacy of lawsonia alba in the alleviation of carbon tetrachlo-
ride-induced oxidative stress. J. Ethanopharmacol. 69, 157–164.
Chopra, R.N., Nair, S.L., Chopra, J.C., 1981. Glossary of Indian
Medicinal Plants. CSIR Publication, New Delhi, 50.
Chung, W.H., Chang, Y.C., Yang, L.J., Hung, S.I., Wong, W.R., Lin,
J.Y., 2002. Clinicopathologic features of skin reactions to tempo-
rary tattoos and analysis of possible causes. Arch. Dermatol., 138–
188.
Gaze, D.C., 2007. The role of existing and novel cardiac biomarkers
for cardioprotection. Curr. Opin. Invest. Drugs 8 (9), 711–717.
Haiping, Li, Xiaoxiang, Lu, Meijun, Lu, Hongmei, Liu, 2008.
Isolation, puriﬁcation and antitumor activity of lipopolysaccharide
from cow placenta. Int. J. Biol. Macromol. 43, 232–237.
Harada, M., Udagawa, N., Fukasawa, K., Hiraoka, B.Y., Mogi, M.,
1986. Inorganic pyrophosphatase activity of puriﬁed bovine pulp
alkaline phosphatase at physiological pH. J. Dent. Res. 65 (2), 125–
127.
Jagethia, G.C., Baliga, MS., 2003. Correa inhibits the proliferation of
transplanted Erlich Ascites Carcinoma in mice. Biol. Pharm. Bull.
28, 58–64.
Kadam, S.S., Mahadik, K.R., Bothra, K.G., 1989. Principle of
Medicinal Chemistry, ﬁrst ed. Nirali Prakashan, p. 86.
Kazandjieva, J., Grozdev, I., Tsankov, N., 2007. Temporary henna
tattoos. Clin. Dermatol. 25, 383–387.
Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J.,
Cummings, O.W., Ferrell, L.D., Liu, Y.C., Torbenson, M.S.,
Unalp-Arida, A., Yeh, M., McCullough, A.J., Sanyal, A.J., 2005.
Nonalcoholic steatohepatitis clinical research network, design and
validation of a histological scoring system for nonalcoholic fatty
liver disease. Hepatology 41, 1313–1321.
Effect of Lawsonia inermis on tumor expression induced 359Lee, K.K., Shimoji, M., Hossain, Q.S., Sunakawa, H., 2008. Novel
function of glutathione transferase in rat liver mitochondrial
membrane: role for cytochrome c release from mitochondria.
Toxicol. Appl. Pharmacol. 232, 109–118.
Maritim, A.C., Sanders, R.A., Watkins, J.B., 2003. Diabetes, oxidative
stress, and antioxidants, a review. J. Biochem. Mol. Toxicol. 17,
24–38.
Marklund, S.I., Westman, N.G., Lundgren Roos, G., 1984. Copper
and zinc containing superoxide dismutase, catalase and glutathine
peroxidase in normal and neoplastic human celline and normal
human tissues. Cancer Res. 42, 1955–1961.Mate´s, J.M., Sanchez-Jime´nez, F., 1999. Antioxidant enzymes and
their implications in pathophysiologic processes. Front. Biosci. 4,
339–345.
Noctor, G., Foyer, C.H., 1998. Ascorbate and glutathione: keeping
active oxygen under control. Ann. Rev. Plant Physiol. Plant Mol.
Biol. 49, 249–279.
Sivakumar, P., Sambath kumar, R., Sivakumar, T., Nethaji, R.,
Vijayabaskaran, M., Perumal, P., Bukkawer, A.R., Jayakar, B.,
Parvathi, K., Sarasu, 2008. Antitumor and antioxidant activities of
Triumfetta rhomboidea against Dalton’s Ascites Lymphoma bear-
ing swiss albino mice. Res. J. Med. Sci. 2 (4), 203–208.
